for STC008 Injection

About this update from Beijing Sun-novo Pharmaceutical Research Co. Ltd. Class A

Announcement on the Signing of the “Supplementary Agreement to the Technology Development Contract” for STC008 Injection The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Beijing Sun-novo Pharmaceutical Research Co. Ltd. Class A